View by Specialty

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

Juvenile Arthritis News

SPONSORED CONTENT
Save
SPONSORED CONTENT
March 08, 2023
1 min read
Save

Young age, adverse drug reactions may signal lung disease in juvenile idiopathic arthritis

Young age, adverse drug reactions may signal lung disease in juvenile idiopathic arthritis

SCOTTSDALE, Ariz. — The prevalence of systematic-onset juvenile idiopathic arthritis-related lung disease appears to be on the rise, and being aware of clinical manifestations is important for catching the disease early, a speaker said.

SPONSORED CONTENT
February 22, 2023
2 min read
Save

Conventional memory B, T cells potential biomarkers for juvenile dermatomyositis

Conventional memory B, T cells potential biomarkers for juvenile dermatomyositis

Conventional memory B cells with low CXCR5 levels and CXCR5 T-helper 2 memory cells are potential biomarkers of juvenile dermatomyositis disease activity, according to data published in Arthritis & Rheumatology.

Trending

DERM1124DesaiQAGraphic01
November 11, 2024
6 min read
Save

Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access

SPONSORED CONTENT
February 09, 2023
2 min read
Save

Remission the primary T2T goal in childhood-onset lupus, say new points to consider

Remission the primary T2T goal in childhood-onset lupus, say new points to consider

Remission should be the primary goal for patients with childhood-onset systemic lupus erythematosus, according to new points to consider for treat-to-target endorsed by the Pediatric Rheumatology European Society.

SPONSORED CONTENT
February 08, 2023
2 min read
Save

Rates of depression, anxiety in juvenile arthritis comparable to general population

Rates of depression, anxiety in juvenile arthritis comparable to general population

Patients with juvenile idiopathic arthritis do not appear to have an increased risk for anxiety or depression, compared with the general population, according to data published in Pediatric Rheumatology.

SPONSORED CONTENT
February 07, 2023
2 min read
Save

High fevers, left ventricular dysfunction may predict severe MIS-C

High fevers, left ventricular dysfunction may predict severe MIS-C

Key risk factors that may predict severe disease in patients with MIS-C include fever greater than 103.1 degrees Fahrenheit, central nervous system involvement and left ventricular dysfunction, according to data published in Rheumatology.

SPONSORED CONTENT
February 07, 2023
2 min read
Save

Some patients with familial Mediterranean fever may achieve colchicine-free remission

Some patients with familial Mediterranean fever may achieve colchicine-free remission

A small minority of patients with familial Mediterranean fever may be able to achieve colchicine-free remission, according to data published in Pediatric Rheumatology.

SPONSORED CONTENT
February 06, 2023
2 min read
Save

Pain distribution less indicative of impairment than other factors in juvenile fibromyalgia

Pain distribution less indicative of impairment than other factors in juvenile fibromyalgia

In patients with juvenile fibromyalgia, pain distribution throughout the body may be less important for clinical outcomes and impairment than other factors, according to data published in Arthritis Care & Research.

SPONSORED CONTENT
January 17, 2023
2 min read
Save

Family history of autoimmune disease a risk factor for juvenile idiopathic arthritis

Family history of autoimmune disease a risk factor for juvenile idiopathic arthritis

Family history of autoimmune disease is a risk factor for developing of juvenile idiopathic arthritis, although it does not impact disease severity or course, according to data published in Pediatric Rheumatology.

SPONSORED CONTENT
January 11, 2023
2 min read
Save

Etanercept, adalimumab improve wellbeing in non-systemic juvenile idiopathic arthritis

Etanercept, adalimumab improve wellbeing in non-systemic juvenile idiopathic arthritis

Etanercept and adalimumab are both impactful at improving the health of patients with non-systemic juvenile idiopathic arthritis, according to data published in Pediatric Rheumatology.

SPONSORED CONTENT
January 09, 2023
2 min read
Save

Kawasaki disease diagnoses fell one-third in Japan during first year of COVID pandemic

Kawasaki disease diagnoses fell one-third in Japan during first year of COVID pandemic

The number of patients diagnosed with Kawasaki disease in Japan fell by approximately one-third in 2020, with no indication that parents eschewed necessary hospital visits, according to data published in JAMA Pediatrics.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails